Cisplatin, Docetaxel and Cetuximab (TPEx) as First-line Treatment for Patients With Recurrent or Metastatic Head and Neck Cancer: A Multicenter Real-World Study
暂无分享,去创建一个
M. Rizzo | A. Sola | M. Chacón | A. Falco | F. Waisberg | D. Enrico | M. Leiva | A. Blanco | Guido Cefarelli | J. Melo | F. Cayol | A. Rodríguez | Hernán Rodríguez Montani